Multi-drug-resistant tuberculosis cost-effectiveness of therapy

	Multi-drug-resistant tuberculosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multi-drug-resistant tuberculosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Multi-drug-resistant tuberculosis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multi-drug-resistant tuberculosis cost-effectiveness of therapy
CDC on Multi-drug-resistant tuberculosis cost-effectiveness of therapy
Multi-drug-resistant tuberculosis cost-effectiveness of therapy in the news
Blogs on Multi-drug-resistant tuberculosis cost-effectiveness of therapy
Directions to Hospitals Treating Multi-drug-resistant tuberculosis
Risk calculators and risk factors for Multi-drug-resistant tuberculosis cost-effectiveness of therapy

Overview